Verastem Oncology’s Collaboration With Mirati Therapeutics

Laura Testa
Tagged:

Ropes & Gray advised Verastem Oncology in the deal.Verastem Oncology announced a collaboration to evaluate Mirati Therapeutics’ investigational KRAS inhibitor drug with Verastem’s investigational inhibitor drug in…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

…

This content is for Standard 1 Year members only.
Login Join Now